Archives

by in
Entry Author Date Location
David Schenkein, Cancer Doc Turned CEO, Aims to Build New Genentech 10/16/13 Boston
Broad Institute Joins up with Bayer to Find Targeted Cancer Drugs 09/10/13 Boston
Zuckerberg Takes a Small Step in Right Direction, Backing Biotech 02/25/13 National
East Coast Life Sciences Roundup: IBM, ImmunoGen, Breakthrough Prize, & More 02/22/13 New York
Facebook, Google Moguls Give $33M in Prizes to Biomedical Stars 02/20/13 National
Groupon: The IPO With More Sizzle, and Money, Than the Entire Biotech IPO Class of 2011 11/07/11 National
Langer Nabs Cash From Rock Stars, Verastem Seeks $50M IPO, Alnylam Snags RNAi Collab, & More Boston-Area Life Sciences News 11/04/11 Boston
Verastem, the 15-Month Old Christoph Westphal Venture in Cancer Stem Cells, Seeks IPO 11/03/11 Boston
BuyWithMe Gets Edhance, LogMeIn Picks Up Pachube, Polaris Backs Two MA Companies, & More Boston-Area Deals News 07/20/11 Boston
Amag Eyes Rebound, Idera Surges On Despite Merck KGaA Drop, Verastem Snags $32M, & More Boston-Area Life Sciences News 07/15/11 Boston
Verastem, Rooted at MIT, Raises $32 Million and Adds ATV and Astellas to Slate of Investors 07/14/11 Boston
Termeer Joins Verastem Board 06/13/11 Boston
An Innovation Walk in the Snow: Can You Guess My Route? 01/19/11 Boston
Lilly Funds Cerulean, Genzyme Sells Diagnostics Unit, Roche Ends RNAi Program, & More Boston-Area Life Sciences News 11/19/10 Boston
Verastem, Founded by MIT Big Names, Raises $16M to Fight Cancer Stem Cells 11/16/10 Boston
Foundation Medicine Raises $25M to Get to the Bottom of Cancer Genomes 04/14/10 Boston
The Icos Alumni Guide, Trubion CEO Resigns, OVP Leads $30M Fate Deal, & More Seattle-Area Life Sciences News 11/19/09 Seattle
NanoString Forges Closer Ties With Broad Institute to See What Genetic Tool Can Really Do 11/18/09 Seattle
Obama’s Science and Technology Advisory Council Includes Holdren, Molina, Mundie 04/27/09 National
Born a Creationist, Merck’s Schadt Leads Open Source Effort to Unravel Genome 03/13/09 Seattle
Takeda Takes Hold of Millennium for $8.8 Billion 04/10/08 Boston
What’s Ailing Personalized Medicine? Mark Levin Calls for Leadership at the Highest Level 01/24/08 Boston
Page 1 of 1